Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Apr 22, 16:00
Sinovac Biotech Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 86.71% |
| September 30, 2020 | 87.78% |
| June 30, 2020 | 85.55% |
| March 31, 2020 | 87.13% |
| December 31, 2019 | 84.90% |
| September 30, 2019 | 83.92% |
| June 30, 2019 | 90.49% |
| March 31, 2019 | 89.66% |
| December 31, 2018 | 87.35% |
| September 30, 2018 | 91.37% |
| June 30, 2018 | 85.97% |
| March 31, 2018 | 94.11% |
| December 31, 2016 | 73.46% |
| September 30, 2016 | 80.15% |
| June 30, 2016 | -171.4% |
| March 31, 2016 | 57.77% |
| December 31, 2015 | 68.33% |
| September 30, 2015 | 66.90% |
| June 30, 2015 | 82.25% |
| March 31, 2015 | 74.93% |
| December 31, 2014 | 79.22% |
| September 30, 2014 | 70.92% |
| June 30, 2014 | 74.98% |
| March 31, 2014 | 75.80% |
| December 31, 2013 | 72.16% |
| Date | Value |
|---|---|
| September 30, 2013 | 66.14% |
| June 30, 2013 | 77.88% |
| March 31, 2013 | 70.23% |
| December 31, 2012 | 55.60% |
| September 30, 2012 | 52.61% |
| June 30, 2012 | 85.31% |
| March 31, 2012 | 62.24% |
| December 31, 2011 | 62.01% |
| September 30, 2011 | 56.83% |
| June 30, 2011 | 68.84% |
| March 31, 2011 | 65.40% |
| December 31, 2010 | -20.64% |
| September 30, 2010 | 68.26% |
| June 30, 2010 | 82.70% |
| March 31, 2010 | 80.12% |
| December 31, 2009 | 69.28% |
| September 30, 2009 | 82.68% |
| June 30, 2009 | 81.20% |
| March 31, 2009 | 77.95% |
| December 31, 2008 | 62.66% |
| September 30, 2008 | 81.05% |
| June 30, 2008 | 84.18% |
| March 31, 2008 | 88.18% |
| December 31, 2007 | 68.32% |
| September 30, 2007 | 84.71% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
83.92%
Minimum
Sep 2019
90.49%
Maximum
Jun 2019
86.64%
Average
86.71%
Median
Dec 2020
Gross Profit Margin (Quarterly) Benchmarks
| CASI Pharmaceuticals Inc | 59.05% |
| Zai Lab Ltd | 61.66% |
| I-MAB | -- |
| Gracell Biotechnologies Inc (DELISTED) | -- |
| Adagene Inc | -- |